2010
DOI: 10.4067/s0717-95022010000100007
|View full text |Cite
|
Sign up to set email alerts
|

Diabetic Peripheral Neuropathies: A Morphometric Overview

Abstract: FAZAN, S. V. P.; DE VASCONCELOS, C. C. A.; VALENÇA, M. M.; NESSLER, R. & MOORE, K. C. Diabetic peripheral neuropathies: a morphometric overview. Int. J. Morphol., 28(1):51-64, 2010. SUMMARY: Diabetes is now considered one of the main threats to human health in the 21st century and many researchers are dedicated to investigate the physiopathology of the disease, with further insights on the managements of its major complications. Since understanding the pathophysiology of the major complications of diabetes and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
20
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 96 publications
(112 reference statements)
0
20
0
Order By: Relevance
“…The pathology of diabetes peripheral neuropathy is multifactorial and often studied in the context of a metabolic or vascular etiology (29). From a metabolic perspective, experimental diabetes in rats (model for Type 1 diabetes that causes chronic, severe hyperglycemia ϳ20 -40 mmol/l) results in increased nerve glucose, fructose, polyols, aldose reductase activity, protein kinase C activity, and monoenzymatic protein glycosylation as well as a reduction in nerve myoinositol and sodium potassium ATPase activity (13,15,29,32,51,63). From a vascular perspective, experimental diabetes is linked with reduced endothelial function (37, 50) and nerve blood flow (10,16,36,40,43,50,64).…”
mentioning
confidence: 99%
“…The pathology of diabetes peripheral neuropathy is multifactorial and often studied in the context of a metabolic or vascular etiology (29). From a metabolic perspective, experimental diabetes in rats (model for Type 1 diabetes that causes chronic, severe hyperglycemia ϳ20 -40 mmol/l) results in increased nerve glucose, fructose, polyols, aldose reductase activity, protein kinase C activity, and monoenzymatic protein glycosylation as well as a reduction in nerve myoinositol and sodium potassium ATPase activity (13,15,29,32,51,63). From a vascular perspective, experimental diabetes is linked with reduced endothelial function (37, 50) and nerve blood flow (10,16,36,40,43,50,64).…”
mentioning
confidence: 99%
“…DPN affects up to 50% of the patients after 25 years of disease, being associated to 50-75% of non traumatic amputations [3,4]. The prevalence of diabetic neuropathies is dramatically increasing with the enormous burden of type-2 diabetes, but the true occurrence remains unrevealed, with variable reports in diabetic patients depending mostly on the criteria and methods used to identify neuropathy [5,6]. Frequently, patients with nerve damage have no symptoms, whilst most part have extremely painful symptoms, such as burning pain, squeezing, constricting, freezing, allodynia or non-painful neuropathic deficits, such as asleep, tingling, numbness-loss of feeling in the hands, arms, feet, and legs [3,5].…”
Section: Contextmentioning
confidence: 99%
“…Malnutrition could change these neurophysiological mechanisms, as well as diabetesassociated malnutrition or non-associated, therefore it showed a new type of mixed peripheral neuropathy [5,6,7]. With regard to the vestibulocochlear nerve (VIII cranial nerve) in large magnifications, the greatest evidence was axonal atrophy and cytoplasmic intumescent (Figures 1 and 2-5).…”
Section: Introductionmentioning
confidence: 99%